FDA Panel Votes on First Multi-Cancer Blood Test
#CancerDetection #FDAFDA advisers vote today on approving Galleri, the first multi-cancer blood test, detecting up to 50 cancers. Grail seeks approval despite mixed trial results. Medicare coverage and insurance reimbursement hinge on FDA decision, potentially transforming early cancer detection. read more
There are no other CancerDetection articles to read at this time.
Check out some of these other topics...